Menu Search
Equities

CVS Health Corp

CVS:NYQ

CVS Health Corp

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)55.90
  • Today's Change0.75 / 1.36%
  • Shares traded23.95m
  • 1 Year change-20.23%
  • Beta0.5520
Data delayed at least 15 minutes, as of May 03 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 02-May-24
Select bar for recommendation details.
Recommendations02-May-24
Buy4
Outperform12
Hold13
Underperform0
Sell0

Share price forecast in USD

The 24 analysts offering 12 month price targets for CVS Health Corp have a median target of 67.00, with a high estimate of 99.00 and a low estimate of 60.00. The median estimate represents a 19.86% increase from the last price of 55.90.
High77.1%99.00
Med19.9%67.00
Low7.3%60.00

Dividends in USD

In 2023, CVS Health Corp reported a dividend of 2.64 USD, which represents a 19.85% increase over last year. The 10 analysts covering the company expect dividends of 2.54 USD for the upcoming fiscal year, a decrease of 3.75%.
Div growth (TTM)19.85%
More ▼

Earnings history & estimates in USD

On May 01, 2024, CVS Health Corp reported 1st quarter 2024 earnings of 1.31 per share.
The next earnings announcement is expected on Jul 31, 2024.
Average growth rate-10.46%
CVS Health Corp reported annual 2023 earnings of 8.74 per share on Feb 07, 2024.
Average growth rate+5.49%
More ▼

Revenue history & estimates in USD

CVS Health Corporation had 1st quarter 2024 revenues of 88.44bn. This missed the 89.21bn consensus estimate of the 19 analysts following the company. This was 3.70% above the prior year's 1st quarter results.
Average growth rate+1.00%
CVS Health Corporation had revenues for the full year 2023 of 357.78bn. This was 10.95% above the prior year's results.
Average growth rate+8.67%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.